Yıl: 2021 Cilt: 24 Sayı: 2 Sayfa Aralığı: 174 - 184 Metin Dili: İngilizce DOI: 10.31086/tjgeri.2021.213 İndeks Tarihi: 26-05-2022

BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE

Öz:
Introduction: The number of elderly patients with bladder cancer is expected to triple in the coming years in proportion to the increasing elderly population in the world. The aim of this study was to identify the prognostic factors affecting survival among elderly patients undergoing chemoradiotherapy for muscle-invasive bladder cancer. Materials and Method: We retrospectively reviewed medical records from 93 biopsy-proven nonmetastatic elderly patients with bladder cancer ≥ 65 years who were treated with helical tomotherapy. The patients received 64.8 Gy to the bladder with concurrent intravenous cisplatin (40 mg/m2) chemotherapy weekly as a radiosensitizer. Results: The mean follow-up time was 34.1 months (range, 4.0–99.1 months). The two- and five-year overall survival, disease-free survival, and cancer-specific survival rates were 70.6%, and 36.9%, 50.6% and 28.5%, 89.1%, and 58.5%, respectively. Multivariate analysis indicated that urothelial obstruction was an independent prognostic factor affecting survival rates. No grade 4 adverse events and deaths attributable to treatment occurred during chemoradiotherapy Conclusion: Image guided radiotherapy with chemotherapy as a bladder- sparing approach is a tolerable alternative therapeutic option without severe acute and late toxicities in elderly patients who are unfit for radical cystectomy or refuse surgery.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Siegel RL, Miller KD, Jemal A. Cancer statistics. Can- cer J. Clin. 2017; 67(1): 7-30. (PMID: 28055103)
  • 2. Lobo N, Mount C, Omar K, et al. Landmarks in the treatment of muscle-invasive bladder cancer. Nat Rev Urol 2017; 14(9): 565-574. (PMID: 28675174)
  • 3. Leow JJ, Reese S, Trinh QD, Bellmunt et al. Impact of surgeon volume on the morbidity and costs of rad- ical cystectomy in the USA: a contemporary popu- lation-based analysis. BJU International 2015;115(5): 713-721. (PMID: 24674655)
  • 4. Giacalone NJ, Shipley WU, Clayman RH, et al. Long- term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the Massachusetts General Hospital Experience. Eur Urol 2017; 71(6): 952-960. (PMID: 28081860)
  • 5. Jahnson S, Pedersen J, Westman G. Bladder carci- noma - a 20-year review of radical irradiation ther- apy. Radiother Oncol 1991; 22(2): 111-117. (PMID: 1957001)
  • 6. Hamad J, McCloskey H, Milowsky M, et al. Bladder preservation in muscle-invasive bladder cancer: a comprehensive review. International Braz J Urol 2020: 46(2); 184-169. (PMID: 31961624)
  • 7. Turgeon AN, Souhami L. Trimodality therapy for bladder preservation in elderly population with in- vasive bladder cancer. Front Oncol 2014: 4(206): 1-9. (PMID: 25140295)
  • 8. Tekin A, Şengör F. The place of radical cystectomy in treatment of bladder cancer in elderly Turkish Jour- nal of Urology 2006; 32(1): 8-13. (in Turkish)
  • 9. Jemal A, Siegel R, XU J. Ward E: Cancer statistics. CA Cancer J Clin 2010; 60(5): 277-300. (PMID: 20610543)
  • 10. Shariat SF, Sfakianos JP, Droller MJ, et al. The effect of age and gender on bladder cancer: a critical re- view of the literature. BJU Int 2009; 105(3): 300-308. (PMID: 19912200)
  • 11. Nuclear morphometry in typing and grading urothe- lial neoplasms of urinary bladder. Turkish Pathology Journal 2007: 23(11); 16-20. (in Turkish)
  • 12. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005; 66(Suppl 1): 4–34. (PMID: 16399414)
  • 13. Iida S, Kondo T, Kobayashi H, et al. Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience. Int J Urol 2009; 16(3): 287-292. (PMID: 19207115)
  • 14. Wakai K, Utsumi T, Oka R, et al. Clinical predictors for high-grade bladder cancer before first-time tran- surethral resection of the bladder tumor: a retro- spective cohort study. Japanese J of Clinical Oncol- ogy 2016; 46(10): 964-967. (PMID: 27511986)
  • 15. Kaufman DS, Shipley WU, Griffin PP, et al. Selective bladder preservation by combination treatment of invasive bladder cancer. N Engl J Med. 1993; 329(19): 1377-1382. (PMID: 8413433)
  • 16. Shipley WU, Kaufman DS, Zehr E, et al. Selective bladder preservation by combined modality proto- col treatment: long term outcomes of 190 patients with invasive bladder cancer. Urology 2002; 60(1): 62- 68. (PMID: 12100923)
  • 17. Zhang S, Yu YH, Zhang Y, et al. Radiotherapy in mus- cle-invasive bladder cancer: the latest research pro- gress and clinical application. Am J Cancer Res 2015; 5(2): 854-868. (PMID: 25973322)
  • 18. Korpic MC, Blok AM, Martin B, et al. The Impact of Radiation Therapy Dose on Survival in Patients with Muscle-Invasive Bladder Cancer: A Popula- tion-Based Analysis. Int J Radiat Oncol Biol Phys (Abstact) 2016; 96(2):S183.
  • 19. Tester W, Porter A, Asbell S, et al. Combined mo- dality program with possible organ preservation for invasive bladder carcinoma: results of RTOG proto- col 85–12. Int J Radiat Oncol Biol Phys. 1993; 25(5): 783-790. (PMID: 8478228)
  • 20. Kaufman DS, Winter KA, Shipley WU, et al. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radi- cal cystectomy and adjuvant chemotherapy. Urology 2009; 73(4): 833-837. (PMID: 19100600)
  • 21. Atasoy BM, Dane f, Cetin IA. Concurrent chemoradi- otherapy with low dose weekly gemcitabine in med- ically inoperable muscle-invasive bladder cancer patients. Clinical and Translational Oncology 2014: 16(1); 91-95. (PMID: 23615982)
  • 22. Hoskin PJ, Rojas AM, Bentzen SM, et al. Radiother- apy with concurrent carbogen and nicotinamide in bladder carcinoma. J Clin Oncol 2010; 28(33): 4912- 4918. (PMID: 20956620)
  • 23. James N, Hussain SA, Hall E, et al. Results of a 2×2 phase III randomized trial of synchronous chemo-ra- diotherapy compared to radiotherapy alone and standard versus reduced high dose volume radio- therapy in muscle-invasive bladder cancer. J Clin Oncol 2010; 28(p15):(Abstr 4517). DOI:10.1016/j. ijrobp.2010.07.048
  • 24. Hussain SA, Stocken DD, Peake DR, et al. Long-term results of a phase II study of synchronous chemo- radiotherapy in advanced muscle-invasive bladder cancer. Br J Cancer. 2004; 90(11): 2106-2111. (PMID: 15150587)
  • 25. Asadauskiene J, Aleknavicius E, Zelviene TP, et al. The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer. Me- dicina Kaunas 2010; 46(5): 305-14. (PMID: 20679745)
APA AYNACI Ö, TÜRKER SERDAR L, yaşar zengin a, Savli E, HANEDAN USLU G, gedik s (2021). BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE. , 174 - 184. 10.31086/tjgeri.2021.213
Chicago AYNACI ÖZLEM,TÜRKER SERDAR LASİF,yaşar zengin ahmet,Savli Evrim,HANEDAN USLU Gonca,gedik sonay BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE. (2021): 174 - 184. 10.31086/tjgeri.2021.213
MLA AYNACI ÖZLEM,TÜRKER SERDAR LASİF,yaşar zengin ahmet,Savli Evrim,HANEDAN USLU Gonca,gedik sonay BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE. , 2021, ss.174 - 184. 10.31086/tjgeri.2021.213
AMA AYNACI Ö,TÜRKER SERDAR L,yaşar zengin a,Savli E,HANEDAN USLU G,gedik s BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE. . 2021; 174 - 184. 10.31086/tjgeri.2021.213
Vancouver AYNACI Ö,TÜRKER SERDAR L,yaşar zengin a,Savli E,HANEDAN USLU G,gedik s BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE. . 2021; 174 - 184. 10.31086/tjgeri.2021.213
IEEE AYNACI Ö,TÜRKER SERDAR L,yaşar zengin a,Savli E,HANEDAN USLU G,gedik s "BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE." , ss.174 - 184, 2021. 10.31086/tjgeri.2021.213
ISNAD AYNACI, ÖZLEM vd. "BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE". (2021), 174-184. https://doi.org/10.31086/tjgeri.2021.213
APA AYNACI Ö, TÜRKER SERDAR L, yaşar zengin a, Savli E, HANEDAN USLU G, gedik s (2021). BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE. Türk Geriatri Dergisi, 24(2), 174 - 184. 10.31086/tjgeri.2021.213
Chicago AYNACI ÖZLEM,TÜRKER SERDAR LASİF,yaşar zengin ahmet,Savli Evrim,HANEDAN USLU Gonca,gedik sonay BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE. Türk Geriatri Dergisi 24, no.2 (2021): 174 - 184. 10.31086/tjgeri.2021.213
MLA AYNACI ÖZLEM,TÜRKER SERDAR LASİF,yaşar zengin ahmet,Savli Evrim,HANEDAN USLU Gonca,gedik sonay BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE. Türk Geriatri Dergisi, vol.24, no.2, 2021, ss.174 - 184. 10.31086/tjgeri.2021.213
AMA AYNACI Ö,TÜRKER SERDAR L,yaşar zengin a,Savli E,HANEDAN USLU G,gedik s BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE. Türk Geriatri Dergisi. 2021; 24(2): 174 - 184. 10.31086/tjgeri.2021.213
Vancouver AYNACI Ö,TÜRKER SERDAR L,yaşar zengin a,Savli E,HANEDAN USLU G,gedik s BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE. Türk Geriatri Dergisi. 2021; 24(2): 174 - 184. 10.31086/tjgeri.2021.213
IEEE AYNACI Ö,TÜRKER SERDAR L,yaşar zengin a,Savli E,HANEDAN USLU G,gedik s "BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE." Türk Geriatri Dergisi, 24, ss.174 - 184, 2021. 10.31086/tjgeri.2021.213
ISNAD AYNACI, ÖZLEM vd. "BLADDER PRESERVATION WITH IMAGE- GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE". Türk Geriatri Dergisi 24/2 (2021), 174-184. https://doi.org/10.31086/tjgeri.2021.213